- Home
- EM vs MOLN Comparison
EM vs MOLN Comparison
Compare EM & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- MOLN
- Stock Information
- Founded
- EM 2017
- MOLN 2004
- Country
- EM China
- MOLN Switzerland
- Employees
- EM N/A
- MOLN N/A
- Industry
- EM Other Consumer Services
- MOLN
- Sector
- EM Consumer Discretionary
- MOLN
- Exchange
- EM Nasdaq
- MOLN Nasdaq
- Market Cap
- EM 297.2M
- MOLN 192.4M
- IPO Year
- EM 2021
- MOLN 2021
- Fundamental
- Price
- EM $1.16
- MOLN $5.04
- Analyst Decision
- EM Strong Buy
- MOLN
- Analyst Count
- EM 1
- MOLN 0
- Target Price
- EM $1.00
- MOLN N/A
- AVG Volume (30 Days)
- EM 1.9M
- MOLN 5.7K
- Earning Date
- EM 03-27-2025
- MOLN 03-13-2025
- Dividend Yield
- EM 2.29%
- MOLN N/A
- EPS Growth
- EM N/A
- MOLN N/A
- EPS
- EM 0.03
- MOLN N/A
- Revenue
- EM $269,745,696.00
- MOLN $7,105,397.00
- Revenue This Year
- EM N/A
- MOLN N/A
- Revenue Next Year
- EM $6.16
- MOLN $29.41
- P/E Ratio
- EM $35.33
- MOLN N/A
- Revenue Growth
- EM N/A
- MOLN N/A
- 52 Week Low
- EM $0.46
- MOLN $3.32
- 52 Week High
- EM $1.18
- MOLN $12.70
- Technical
- Relative Strength Index (RSI)
- EM 81.97
- MOLN 41.97
- Support Level
- EM $1.11
- MOLN $5.22
- Resistance Level
- EM $1.17
- MOLN $5.35
- Average True Range (ATR)
- EM 0.03
- MOLN 0.12
- MACD
- EM -0.00
- MOLN -0.03
- Stochastic Oscillator
- EM 91.89
- MOLN 0.00
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.